Your browser doesn't support javascript.
loading
Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.
Boyce, Malcolm; van den Berg, Frans; Mitchell, Toni; Darwin, Kate; Warrington, Steve.
Afiliação
  • Boyce M; Hammersmith Medicines Research, Cumberland Avenue, London, NW10 7EW, UK. mboyce@hmrlondon.com.
  • van den Berg F; Hammersmith Medicines Research, Cumberland Avenue, London, NW10 7EW, UK.
  • Mitchell T; Hammersmith Medicines Research, Cumberland Avenue, London, NW10 7EW, UK.
  • Darwin K; Hammersmith Medicines Research, Cumberland Avenue, London, NW10 7EW, UK.
  • Warrington S; Hammersmith Medicines Research, Cumberland Avenue, London, NW10 7EW, UK.
Eur J Clin Pharmacol ; 73(2): 129-139, 2017 Feb.
Article em En | MEDLINE | ID: mdl-27796466
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Benzodiazepinonas / Gastrinas / Receptor de Colecistocinina B / Inibidores da Bomba de Prótons / Esomeprazol / Antiulcerosos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Benzodiazepinonas / Gastrinas / Receptor de Colecistocinina B / Inibidores da Bomba de Prótons / Esomeprazol / Antiulcerosos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article